Steven Love Biography and Net Worth

Director of OmniAb

Steve Love has served as the Chief Financial Officer at Sift Science, Inc., an AI platform-based company for identity-centric fraud prevention since April 2024. Prior to Sift, Mr. Love served as Chief Financial Officer at Heap Inc., a global SaaS product analytics company from 2021 to 2023. Prior to Heap, Mr. Love served as Chief Financial Officer at Juniper Square Inc. from 2020 to 2021. Mr. Love has spent nearly 30 years in finance, leading the growth strategy and data-driven decision-making at DialPad Inc., Mblox Inc., Evolv Inc., Affymax, Inc., and Connetics Corporation, among others. He began his career at Ernst & Young LLP, supporting private and public biotechnology and software companies. Mr. Love holds a Masters in Accounting and a B.S. in Accounting from the University of Southern California and is a Certified Public Accountant in California (inactive).

What is Steven Love's net worth?: The estimated net worth of Steven Love is at least $75.52 thousand as of May 14th, 2025. Mr. Love owns 38,333 shares of OmniAb stock worth more than $75,516 as of December 5th. This net worth evaluation does not reflect any other investments that Mr. Love may own. Learn More about Steven Love's net worth.
How do I contact Steven Love?: The corporate mailing address for Mr. Love and other OmniAb executives is 65 EAST 55TH STREET 18TH FLOOR, NEW YORK NY, 10022. OmniAb can also be reached via phone at 510-250-7800 and via email at [email protected]. Learn More on Steven Love's contact information.
Has Steven Love been buying or selling shares of OmniAb?: Steven Love has not been actively trading shares of OmniAb within the last three months. Most recently, on Wednesday, May 14th, Steven Love bought 25,000 shares of OmniAb stock. The stock was acquired at an average cost of $1.46 per share, with a total value of $36,500.00. Following the completion of the transaction, the director now directly owns 38,333 shares of the company's stock, valued at $55,966.18. Learn More on Steven Love's trading history.
Who are OmniAb's active insiders?: OmniAb's insider roster includes Charles Berkman (Insider), Matthew Foehr (President and CEO), Kurt Gustafson (CFO), John Higgins (Director), and Steven Love (Director). Learn More on OmniAb's active insiders.
Are insiders buying or selling shares of OmniAb?: In the last year, OmniAb insiders bought shares 5 times. They purchased a total of 293,011 shares worth more than $533,319.37. In the last year, insiders at the sold shares 9 times. They sold a total of 150,811 shares worth more than $458,129.12. The most recent insider tranaction occured on November, 7th when Director John L Higgins bought 41,038 shares worth more than $56,632.44. Insiders at OmniAb own 8.6% of the company. Learn More about insider trades at OmniAb.
Information on this page was last updated on 11/7/2025.

Steven Love Insider Trading History at OmniAb

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/14/2025	Buy	25,000	$1.46	$36,500.00	38,333

Steven Love Buying and Selling Activity at OmniAb

OmniAb Company Overview

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

Today's Range

Now: $1.97

$1.86

$1.98

50 Day Range

MA: $1.64

$1.38

$1.97

2 Week Range

Now: $1.97

$1.22

$4.17

Volume

454,821 shs

Average Volume

503,386 shs

Market Capitalization

$283.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.13